从United States供应商批发进口Abbott Binaxnow Covid 15 Min Self Tests — FOB条款

The Abbott BinaxNOW Covid 15 Min Self Tests are immunological reagent kits designed for rapid antigen detection of SARS-CoV-2 via nasal swab, producing qualitative results in fifteen minutes without laboratory equipment or trained personnel. Each kit contains forty individual test cards, with palletised shipments holding 160 kits (6,400 tests total). Worldsource PPE LLC offers these as FDA Emergency Use Authorized devices restricted to distribution and use within the United States only. The source lists a special one-time test order of ten kits (400 tests) at $10.50 USD per test, though buyers should confirm current availability and pricing directly with the supplier.

The test employs a lateral flow immunochromatographic assay targeting nucleocapsid protein antigens, with standard rapid antigen test sensitivity typically ranging 80-95% and specificity above 97% when compared to PCR reference methods. The nasal swab collection method reduces sampling complexity versus nasopharyngeal swabs, though proper anterior nares technique remains essential for valid results. Abbott's NAVICA smartphone app integration allows digital result display for workplace, educational, or venue entry verification. Test cards are single-use with built-in control line validation; room temperature storage is standard, though exact shelf life and temperature limits should be verified with Worldsource PPE LLC for each lot received.

Primary buyers include US pharmacy chains, clinic networks, employer health programs, and government procurement agencies seeking point-of-care or at-home screening capacity. The fifteen-minute turnaround supports same-day decision making for isolation and contact tracing protocols. Bulk importers must ensure FDA EUA compliance, proper cold chain or ambient storage during transit, and chain of custody documentation for federal or state emergency distribution programs. Confirm with Worldsource PPE LLC whether their harbor-tier status affects shipment scheduling, response timelines, or minimum order flexibility.

Worldsource PPE LLC is headquartered at 229 S. Main Street, Thiensville, Wisconsin 53092, United States. The supplier carries a harbor-tier trust classification and currently shows a 0.00% response rate with zero average response hours recorded, which buyers should factor into communication expectations and order planning. The listing presents no verification badges, transaction history, or third-party audit disclosures beyond the tier assignment. What the profile does state is a physical US address and product-specific sourcing for Abbott-branded diagnostic kits; what it does not state is manufacturing capability, inventory held, or direct contractual relationship with Abbott Laboratories.

The supplier's offering centres on bulk procurement of BinaxNOW test kits for domestic US distribution channels, with explicit geographic restriction to the United States market. The source description mentions parallel availability of Abbott PANBIO COVID-19 rapid self-test cards for outside-US markets, suggesting some international product knowledge, though buyers should verify whether Worldsource PPE LLC actually stocks or brokers both lines. No employee count, year established, revenue figure, or client references appear in the profile, so claims about scale or market position cannot be substantiated from available data.